The authors estimate that testing HbA1c every three months halved the proportion of patients showing a significant (≥9.9%) rise in HbA1c compared to annual testing (7–10 vs. 15–20%). Testing more frequently did not appear to provide any additional benefit. They say that their findings support international guidance.
NICE recommends HbA1c testing at 2–6-monthly intervals (tailored to individual needs) in both type 1 and type 2 diabetes. For those with type 2 diabetes and stable glucose levels and therapy, testing frequency can be reduced to every 6 months.